Evidence that nasal insulin induces immune tolerance to insulin in adults with autoimmune diabetes
about
Beta cell antigens in type 1 diabetes: triggers in pathogenesis and therapeutic targetsAntigen-based immunotherapy for autoimmune disease: current statusType 1 diabetes: translating mechanistic observations into effective clinical outcomesLong-lasting immune responses 4 years after GAD-alum treatment in children with type 1 diabetes.Antigen-based vs. systemic immunomodulation in type 1 diabetes: the pros and cons.Autoreactive T cells specific for insulin B:11-23 recognize a low-affinity peptide register in human subjects with autoimmune diabetesTransient B-cell depletion with anti-CD20 in combination with proinsulin DNA vaccine or oral insulin: immunologic effects and efficacy in NOD mice.Vaccination against type 1 diabetes.Antigen-specific therapeutic approaches in Type 1 diabetesIntranasal glucagon: a promising approach for treatment of severe hypoglycemiaBeyond HLA-A*0201: new HLA-transgenic nonobese diabetic mouse models of type 1 diabetes identify the insulin C-peptide as a rich source of CD8+ T cell epitopes.Three sensitive assays do not provide evidence for circulating HuD-specific T cells in the blood of patients with paraneoplastic neurological syndromes with anti-Hu antibodies.HLA-B7-restricted islet epitopes are differentially recognized in type 1 diabetic children and adults and form weak peptide-HLA complexes.Primary and secondary prevention of Type 1 diabetesNew and future immunomodulatory therapy in type 1 diabetes.Mechanistic basis of immunotherapies for type 1 diabetes mellitusImmunotherapy trials for type 1 diabetes: the contribution of George Eisenbarth.Regulatory T Cell Dysfunction Acquiesces to BTLA+ Regulatory B Cells Subsequent to Oral Intervention in Experimental Autoimmune EncephalomyelitisClinical potential of antigen-specific therapies in type 1 diabetes.Phenotypic and environmental factors associated with elevated autoantibodies at clinical onset of paediatric type 1 diabetes mellitus.Inducing immune tolerance: a focus on Type 1 diabetes mellitus.Plant-based vaccines for oral delivery of type 1 diabetes-related autoantigens: Evaluating oral tolerance mechanisms and disease prevention in NOD mice.Immunomodulatory therapy to preserve pancreatic β-cell function in type 1 diabetes.Pathogenic and regulatory T cells in type 1 diabetes: losing self-control, restoring it, and how to take the temperature.Making progress: preserving beta cells in type 1 diabetes.Through the fog: recent clinical trials to preserve β-cell function in type 1 diabetes.Clinical immunologic interventions for the treatment of type 1 diabetes.Effects of vitamin D on antigen-specific and non-antigen-specific immune modulation: relevance for type 1 diabetes.Emerging immune therapies in type 1 diabetes and pancreatic islet transplantation.Trials in type 1 diabetes: Antigen-specific therapies.Progress in immune-based therapies for type 1 diabetes.Antigen-based vaccination and prevention of type 1 diabetes.Programming of neuroendocrine self in the thymus and its defect in the development of neuroendocrine autoimmunity.Predictors of progression to Type 1 diabetes: preparing for immune interventions in the preclinical disease phase.Immune modulation in humans: implications for type 1 diabetes mellitus.Less is more: the detrimental consequences of immunosuppressive therapy in the treatment of type-1 diabetes.Biomarkers for antigen immunotherapy in allergy and type 1 diabetes.Tolerogenic Nanoparticles to Treat Islet Autoimmunity.Antigen-based immunotherapies do not prevent progression of recent-onset autoimmune diabetes: a systematic review and meta-analysis.Optimization of current and future therapy for autoimmune diseases.
P2860
Q26751244-4DEBA836-08D4-498D-9FDD-7D6F662F0180Q26852915-EBA23CC4-6AFE-4FB4-8591-974A30563A01Q28287737-F44D66EE-B8DD-4562-B0FD-6F6BC33F0461Q34103574-799EAEE9-D8E7-49F7-A03E-D25D25CD0C4DQ34375578-FE5DAA14-0925-4038-99F4-831A1D7C3AE8Q34384116-A3D04E74-3913-4B39-A1DF-7F1F70C03F59Q34583970-457709BC-1E60-4B4B-969E-3F6D8CE3E85AQ35004343-744C8D29-6F03-4B42-8F17-2EAD44A79F85Q35762883-83902F36-78BD-4E21-B711-1B149C0F1C91Q35830445-71E39F55-C680-40CB-B124-7AC90F06B4B2Q35981325-0D6AE6D2-2EE1-4470-9095-BDA3C040E579Q36048199-9CF4C268-8A56-4328-98FC-F9A52E023A39Q36249736-0D916B44-F7A2-4245-A337-4DBC1FEB51F1Q36631971-2F03872A-8723-4355-BEA9-8469140EB784Q36650474-83DE4160-CD13-4678-9966-6BD7F06951EDQ36698793-768D54A0-9AB8-49C8-9286-FE08D065D59CQ36913132-50D5BE46-96F0-44B1-8EF7-09F72FD1A358Q36971195-0F1AC543-FDD2-481A-9838-C22845725C48Q37088212-4401CACA-1958-4310-9DE4-CB433E65BA02Q37390479-FBA2554F-5D41-4002-8DDD-5FC3D902B0EEQ37542678-703CFB76-FB1A-417C-905B-907455D72364Q37638227-D8657482-5A40-4C2D-B184-26EAD057DFD3Q37883029-1E857D12-0D52-4A3A-B9A2-ADDF50F12C5EQ37898049-8A66B565-046A-4EB8-9435-E021FADB9E87Q37972677-4C1881A1-33B4-49DD-A7F9-9FE5EA570082Q38012381-6B88D7D5-D16B-44EC-BD24-CAFD8DC2AF43Q38036230-32A027F0-5418-4DA3-B44B-7F36908F6B77Q38047405-B9131D65-4C24-4D7F-81A2-72212DE9DED0Q38063547-0B2F31C0-474A-4E2D-B6FD-63F521F98C45Q38089387-DFC24368-E5C9-4F98-92AA-0DF2F1F506AAQ38097920-5011FFC6-5E23-4FA1-9979-67D964E07C9CQ38124273-7404FD12-77ED-4D19-A276-4E7FBE90F454Q38153686-BDDC2FDC-0174-451F-9A6E-06EAD7BDA34BQ38161556-5A9BDA3F-7DE0-4522-9093-3B0A62CA8623Q38182297-E5EE7D46-1AB1-4913-9DA9-C68C2965A518Q38385236-E79327E5-5D47-4569-A5F2-7F3ACF8C807DQ38539950-A6C17A6A-176D-4421-927E-4731F118A691Q38645059-3D96B792-5578-4EAC-9B99-4338D82380E7Q38912672-65C97D86-F276-47BA-933C-8728C40A89A5Q39666645-FE050641-3E6F-42E4-AD61-3351A8C1EDAA
P2860
Evidence that nasal insulin induces immune tolerance to insulin in adults with autoimmune diabetes
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Evidence that nasal insulin in ...... dults with autoimmune diabetes
@ast
Evidence that nasal insulin in ...... dults with autoimmune diabetes
@en
Evidence that nasal insulin in ...... dults with autoimmune diabetes
@nl
type
label
Evidence that nasal insulin in ...... dults with autoimmune diabetes
@ast
Evidence that nasal insulin in ...... dults with autoimmune diabetes
@en
Evidence that nasal insulin in ...... dults with autoimmune diabetes
@nl
prefLabel
Evidence that nasal insulin in ...... dults with autoimmune diabetes
@ast
Evidence that nasal insulin in ...... dults with autoimmune diabetes
@en
Evidence that nasal insulin in ...... dults with autoimmune diabetes
@nl
P2093
P2860
P356
P1433
P1476
Evidence that nasal insulin in ...... dults with autoimmune diabetes
@en
P2093
Christine Perry
Jeanne Butler
Leonard C Harrison
Peter G Colman
Shane A Gellert
Spiros Fourlanos
P2860
P304
P356
10.2337/DB10-1360
P407
P577
2011-02-09T00:00:00Z